Healthcare is a complex system that includes activities of management, financing and provision of health services aimed at improving the health status of the country's population. The modern health system is based on the principles of solidarity, choice of efficiency in spending resources on the system and, by its very nature, has both social and economic characteristics. The health care sector is unusual in the extent to which private providers are entrusted with important public roles, and the large amount of public money allocated to health spending in many countries. [1] The role of the State in healthcare systems in most countries is still paramount, although the world's tendencies are towards increasing the liberalization in healthcare services market and the developing competitive environment. Various topics related to medicine have been challenging nowadays including high costs of treatment, associated pressures to cut costs, lack of availability of health insurance, etc. [2] Healthcare encompasses systems designed to offer healthcare services to patients -no matter if regards to prophylaxis, to diagnosis, to treatment or to palliative care -with the ultimate goal of improving one's health. Healthcare systems have a central role in modern society, by providing people with the opportunity to take care of their own health and to improve it. Due to the proper functioning of healthcare systems and the provision of high quality healthcare services, we are able to live better and more intensive live.
Ethics committees developing activities in facilities providing healthcare services are functioning based on the principles of medical ethics and medical law. Such committees have several main functions including draft conclusions on patients' complaints regarding healthcare services, as well as carrying out investigations on unethical relationships between hospital personnel and patients or between patients and trainee students and postgraduate students when professional services are provided at healthcare facilities.
Sometimes ethic committees' competences involve monitoring activities on compliance with the legal requirements for clinical trials of medicinal products, medical equipment and medical devices.
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Scientific research has to be based on ethical standards that promote the protection of human rights. [3] Scientific research must necessarily conform to commonly accepted scientific principles and be based on thorough knowledge of scientific references and other relevant sources of information. Individually identifiable health information should be collected, used, and/or disclosed only to the extent necessary to accomplish a specified purpose(s) and never to discriminate inappropriately. [4] The current legal, regulatory framework in regard to the essence, functions and competences of ethic committees is complex and multi-layered, including regulation on both constitutional and legislative level, as well as a number of legal acts transposing the relevant Directives adopted within the European union. Various guidelines concerning conducting clinical trials are also introduced in national legal acts.
On a national level, the domestic legislation of the Republic of Bulgaria foresees a procedure for obtaining an opinion from the Ethics Committee for multicentre trials in order to introduce a substantial change in a clinical trial and non-interventional studies. This procedure has been implemented pursuant to article 130, para. There are numerous codes of ethics establishing rules and principles in relation to clinical trials such as the Professional Ethics Code, the Ethics Code of the Bulgarian Association for Clinical Trials and the Ethical Codes of the Research Pharmaceutical Industry and Generic Pharmaceutical Manufacturers.
The legislative framework of clinical trials in Bulgaria adopts and introduces European and international rules and standards in regard to planning and conducting clinical trials. Legal definitions of the terms "principal investigator" and "coordinating investigator" have been introduced.
A major change in the performance of clinical trials and non-interventional researches has been achieved as introducing the performance of documentation evaluation.
The "principal investigator" is the medical doctor or the dentist, ho leads the overall execution of the clini-cal trial in accordance with the approved protocol and good clinical practice guidelines. The "coordinating researcher" is a researcher appointed to coordinate researchers from different centres involved in a multicentre trial.
The Law on Medicinal Products in Human Medicine regulates public relations relating the authorization and supervision of the manufacture, use, clinical testing, advertising, import, trade, classification, pharmacovigilance and pricing of medicinal products for human use, as well as the preparation on Positive Drug List. The aim of the law is to create conditions that ensure the placing on the market of medicinal products that meet quality, safety and efficacy requirements. Through this legislative act the harmonization of the Bulgarian drug legislation in accordance with the EU drug legal framework has been achieved and at the same time conditions have been created to guarantee the use of medicinal products that meet the requirements for quality, safety and efficacy.
This law explicitly states that clinical trials may be conducted in compliance with the fundamental principles of human rights and human dignity in regard to protection of any medical and biological study under the Helsinki Declaration and only in hospital care facilities, mental health care centres, Health care centres of skin-venereal diseases, complex oncology centres and diagnostic-consultative centres, which have received a positive accreditation assessment for overall activity. Accreditation has also been required for activities performed in a functional medical institution conducting a clinical trial, in accordance with the Law on the medical institutions.
Particular attention has been paid to clinical trials on minors and adults unable to express their consent freely. The rules on informed consent and the right of withdrawal such consent during the clinical trial performance are being regulated in details. According to the law, liability in case of injuries or deaths caused by or in connection with the conduct of the clinical trial is allocated between the sponsor and the principal investigator.
Tests involving humans are divided into 4 phases: The Clinical Trial in Phase 1 is the first application on patients of the biologically active substance. It is usually performed with the participation of 10 to 20 healthy volunteers in hospitals that have the necessary equipment to conduct such trials. The study aims to determine the pharmacokinetics (i.e., absorption, distribution, metabolism and excretion) of the tested compound, as well as its tolerability.
The Clinical Trial in Phase 2 is the first application of the biologically active compound in patients. It aims to determine its effectiveness, optimal dose and preliminary safety data. Potential differences in pharmacokinetic behavior between healthy volunteers and patients are sought. Several hundred patients are involved in this phase.
The Clinical Trial in Phase 3 aims to investigate the therapeutic relevance, i.e., safety and comparative performance of the product. At this stage, a large number (up to several thousand) patients are involved. Normally, regulatory authorities require the trial to be conducted in a comparative and randomized manner. The Clinical Trial in Phase 4 is performed after Marketing Authorization (post-marketing stage) has been obtained. In this phase, unlike in phases 2 and 3, the longterm use of the product is being studied, following the adverse events that may accompany its use. During the 4th phase, new indications and dosing regimens of the drug are studied, as well as mechanisms of action of the product.
Ethical committees functioning in medical institutions are designed to help doctors and other medical and non-medical specialists, patients and their families inregard to ethical and legal dilemmas they are facing in everyday practice. Committees on professional ethics provide support and professional, competent opinion to healthcare professionals in regard to their responsibilities in medical practice and professional organizational activities. One of the most significant contributions of ethic committees is related to their participation in the regular updating of professional ethic codes. They analyse, explore, compare and systematize the moral norms and values of the healthcare profession. At the core of professional ethics is the category of professionalism, liability and responsibility.
The competences of the Ethics Committees established in the medical institutions in Bulgaria, is related to regulation of the structure and activities of healthcare facilities, as it is possible for the director of the institution to establish a separate code of conduct in regard to ethical attitude in providing healthcare services.
Regulated rules ensuring high standards of ethical conduct are respected by all persons involved in the medical-diagnostic process and overall medical practice, as well as researchers and research team members at every stage of research conducted within the medical institutions.
The current legislative framework allows only a certain range of medical and biological researches to be regulated, which requires synchronizing the activities performed currently by the existing ethics committees within medical institutions in Bulgaria, as this could help in elaboration of a model for optimizing their activities.
Legal, regulatory framework regarding ethic committees competences has not been detailed, as contradictory practices have been observed, due to the fact that a model for optimization of their activities has not been introduced. Appropriate actions toward synchronizing the activities of the ethics committees Bulgaria could have positive effect on the healthcare system in Bulgaria. Regulatory measures could lead to the improvement of the quality of assessment of the ethical norms of conduct in healthcare institutions, as it provides bases for upgrading the quality of the performed healthcare activities.
